ASND (Biotechnology) Stock Valuation & Fair Value Quality business at a reasonable price
ASND (Biotechnology) trades at a blended P/E of 33.7, in line with its historical valuation, with a forward growth estimate of 41.0% and a PEG of 0.82. Analysts' one-year estimates have been hit 30% of the time.
Valuation flags
- No notable valuation flags.
Frequently asked questions
Is ASND overvalued?
At a blended P/E of 33.7, ASND is broadly in line with its historical valuation, with a PEG of 0.82 on 41.0% forward growth. tickerseer currently rates it quality business at a reasonable price.
What is ASND's fair value and PEG?
ASND trades at a blended P/E of 33.7, a PEG of 0.82, and a forward growth estimate of 41.0%.
Has tickerseer's rating of ASND changed?
tickerseer's rating has been quality business at a reasonable price since 2026-07-31.
Industry: Biotechnology. Create a free account to see the full analysis: the SeerAI score, its five quality sub-scores, valuation history, and the AI research note. Options setups and metric history are part of the paid plans.
Get the free weekly earnings preview
One email each Monday with the week's named earnings setups, the reasoning, and what settled last week. Strikes and sizing stay in the paid plan.
It's free, and you can unsubscribe any time. Educational content, not investment advice.